| This article has been cited by |
| 1 | Combined Renin Inhibition/(Pro)Renin Receptor Blockade in Diabetic Retinopathy- A Study in Transgenic (mREN2)27 Rats | |
| Wendy W. Batenburg,Amrisha Verma,Yunyang Wang,Ping Zhu,Mieke van den Heuvel,Richard van Veghel,A. H. Jan Danser,Qiuhong Li,Knut Stieger |
| PLoS ONE.2014;9(6)e100954 |
| [DOI] |
|
| 2 | Novel renin inhibitors containing derivatives of N-alkylleucyl-ß
-hydroxy-?
-amino acids | |
| Iwona Winiecka,Pawel Jaworski,Aleksander Pawel Mazurek,Dorota Marszalek,Anna Goldnik,Daniel Sokulski |
| Journal of Peptide Science.2016;22(2)106 |
| [DOI] |
|
| 3 | Renin–Angiotensin System Blocking Drugs | |
| Nicolás Roberto Robles,Isis Cerezo,Roman Hernandez-Gallego |
| Journal of Cardiovascular Pharmacology and Therapeutics.2014;19(1)14 |
| [DOI] |
|
| 4 | Inhibition of renin and the (pro)renin receptor system | |
| Cuie Guang,Bo Jiang,Robert D. Phillips,Franco Milani |
| Blood Pressure.2012;21(6)377 |
| [DOI] |
|
| 5 | Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications | |
| Hsin-Pei Shih,Xiaodan Zhang,Alex M. Aronov |
| Nature Reviews Drug Discovery.2018;17(1)19 |
| [DOI] |
|
